VOR
Vor Biopharma Inc
18.70$
+3.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.9% | -20.4% | -15.2% | -18.1% | +23.2% | -23.5% | +87.9% | -14.2% | +163.4% | +9.2% | -5.1% | |
| – | -14.4% | -20.6% | -19.3% | -25.4% | +43.4% | -32.8% | +216.0% | -15.8% | +165.6% | +9.3% | -5.1% | |
| – | -30.4% | +43.4% | +69.2% | -30.6% | +55.2% | -38.9% | +285.6% | -16.9% | +147.1% | -57.2% | -36.5% | |
| – | -14.3% | -21.6% | -20.0% | -26.9% | +46.4% | -34.7% | +238.1% | -16.0% | +167.0% | +8.0% | -5.2% | |
| – | +22.5% | -25.6% | -1.1% | -1.1% | +7.4% | -6.5% | +3,856.9% | +40.4% | -73.8% | +4.6% | +3.7% | |
| – | +1.2% | -15.1% | +4.5% | +3.9% | +29.7% | -10.1% | +251.4% | -67.9% | +33.6% | -36.1% | +54.3% | |
| – | +2.3% | +3.3% | +3.9% | +1.2% | +1.2% | +1.2% | – | – | +11.1% | +9.6% | +9.1% | |
| – | -37.7% | +185.3% | -13.7% | -34.4% | +14.4% | +148.0% | -82.1% | +32.3% | +479.3% | -79.7% | +283.3% | |
| – | -13.8% | -18.4% | -20.3% | -25.6% | +32.5% | -31.7% | -2,379.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | +0.2% | +0.4% | +0.2% | +0.4% | +81.7% | +0.4% | +6.7% | +47.7% | -95.6% | +12,525.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.